In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking ...
In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...
and the change in the Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS) from baseline to week 52 (higher scores indicating a better quality of life). Findings showed ...
ROME, NOV 17 - Milan once again conquers the podium, ranking first, followed by Bolzano, second, and Monza and Brianza, third ...
CHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and ...
SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...
In an international trial of 713 adults in nine countries including the U.S. called SUMMIT, participants with heart failure with ...
Two New Analyses from SEQUOIA-HCM Demonstrate Treatment with Aficamten Improves Post-Exercise Oxygen Uptake Recovery and Quality of LifeNew Data ...
Crisugabalin provides significant improvement in average daily pain score and shows promise as a postherpetic neuralgia treatment.
Low-code, no-code approach accelerates eCOA questionnaire design and deployment, taking questionnaire creation, licensing, and localization off the critical path ...
Quality of life (QOL) was measured using the IBS-QOL questionnaire. The primary outcome was the overall bowel symptom score ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback